Divis Laboratories Ltd | DIVI - Interest Expense On Debt



Divis Laboratories Ltd reported 30M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Aurobindo Pharma 1.15B 34.6M Mar/2025
Avita Medical AUD 1.35M 230K Jun/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Lupin 917.6M 26.6M Jun/2025
Moderna USD 1000K 0 Jun/2025
Organon & Co USD 131M 7M Jun/2025
Revvity USD 22.94M 27K Jun/2025
Tectonic Therapeutic USD 17K 5K Jun/2025
Tilray USD 7.77M 2.08M Nov/2024
Viatris USD 116.6M 1.1M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025